U.K. questions NBTY acquisition
This article was originally published in The Tan Sheet
Executive Summary
The U.K. trade regulator says NBTY's acquisition of natural food and ingredients retailer Julian Graves potentially could hinder competition in the nuts, seeds and dried fruit market, and referred the deal for review to its Competition Commission. Because NBTY owns Holland & Barrett, the leading U.K. health food products retailer, the Office of Fair Trading said March 20 it did not receive "sufficient evidence" that other retailers currently adequately constrain NBTY's influence on competition in this area. NBTY and Julian Graves also overlap in vitamins, minerals and supplements sales, but OFT ruled out competition concerns because Julian Graves "sells only limited quantities." Ronkonkoma, N.Y.-based NBTY, which is acquiring Julian Graves through its NBTY Europe subsidiary for approximately $25 million, said it expects the commission's decision by Sept. 3 (1"The Tan Sheet" Sept. 22, 2008, p. 14)
You may also be interested in...
U.K. Play Marks Another NBTY Move Felt By Ingredient Suppliers Everywhere
NBTY increases its influence on competition in the vitamin and dietary supplement ingredient supply market with its acquisition of U.K. natural foods retailer Julian Graves
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.